- A summary of the EAS consensus concerning the causal relationship between low-density lipoproteins and atherosclerotic cardiovascular diseases, prepared by the Board of the Czech Society for Atherosclerosis2019 | First Faculty of Medicine
- The Task Force on the use of antiplatelet in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology2004 | Faculty of Physical Education and Sport
- A summary of the EAS consensus concerning the causal relationship between low-density lipoproteins and atherosclerotic cardiovascular diseases, prepared by the Board of the Czech Society for Atherosclerosis2018 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Statement CSAT on Consensus statement of the European Atherosclerosis Society: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
- The Task Force on the use of antiplatelet in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology +12004 | First Faculty of Medicine
- Sjednocené klinické pokyny pro prevenci ischemické choroby kardiovaskulární. ( Greten, Heiner et al. : Harmonized clinical guidelines on prevention of atherosclerotic cardiovascular disease )2003 | First Faculty of Medicine
- GP's therapeutic preventive care in patients with increased risk of atherosclerotic cardiovascular disease2006 | Faculty of Pharmacy in Hradec Králové
- The potential of diet to affect atherosclerotic cardiovascular diseases2011 | Faculty of Medicine in Hradec Králové
- Atherosclerotic cardiovascular diseases and clinical signifikance of treatment with inclisiran2021 | Faculty of Medicine in Hradec Králové
- Lipid-lowering in diabetes: An update2023 | First Faculty of Medicine
- The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis2021 | Faculty of Pharmacy in Hradec Králové
- Pharmacotherapy of dyslipidemias - an overview of new findings2021 | First Faculty of Medicine
- Current opinion on aspirin in primary prevention of atherosclerotic cardiovascular diseases. Is there any difference between diabetic and non-diabetic patients?2013 | Faculty of Medicine in Pilsen
- LIPIcontrol 2 what has changed after 3 years2020 | First Faculty of Medicine
- The use of inactivation of the ANGPTL3 molecule in the treatment of dyslipidemia2022 | Faculty of Medicine in Hradec Králové
- Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)2023 | First Faculty of Medicine
- Dyslipidemia - the known unknown2023 | First Faculty of Medicine
- ČSAT opinion on the EAS 2021 Consensus: Lipoproteins rich in triglycerides and their remnant particles - overview of metabolism, role in atherosclerotic cardiovascular disease and new therapeutic strategies2022 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology2022 | First Faculty of Medicine
- Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI2023 | First Faculty of Medicine
- Development and trend of lipid modifying therapy in the 21st century2020 | Faculty of Medicine in Pilsen
- Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)2023 | First Faculty of Medicine
- Prediabetes2022 | Faculty of Medicine in Pilsen
- Souhrn konsensu EAS, týkajícího se kauzálního vztahu mezi lipoproteiny o nízké hustotě a aterosklerotickými kardiovaskulárními onemocněními, zpracovaný výborem České společnosti pro aterosklerózu2018 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
- Clinical trials and statistics in cardiology atherosclerosis cardiovascular diseasePublication without faculty affiliation
- Fibrates in treatment of dyslipoproteinemia2006 | Publication without faculty affiliation
- Fibrates in treatment of dyslipoproteinemia +12006 | Faculty of Medicine in Hradec Králové
- Fibrates in treatment of dyslipoproteinemia2006 | First Faculty of Medicine